Pfizer & BioNTech phase 3 COVID-19 vaccine trials resume in SA

Pfizer and BioNTech have started its enrolment of participants in South Africa for its phase 3 COVID-19 vaccine trials.

Thu, 01 Oct 2020 11:18:03 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.